Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 2, 2004

Book review

Preface [Hot topic: Autoimmunity (Executive Editors: D. Stahl and W. Sibrowski)]
pp. i-iii(3)
Authors: Stahl, Dorothea; Sibrowski, Walter

Favourites:
ADD

Review article

Functional Consequences of Immune Cell Adhesion to Endothelial Cells
pp. 109-120(12)
Authors: Rosemblatt, M.; Bono, Maria R.

Favourites:
ADD

Control of Autoimmune Diseases by the B7-CD28 Family Molecules
pp. 121-128(8)
Authors: Anand, Sudarshan; Chen, Lieping

Favourites:
ADD
Favourites:
ADD

Endothelial Chemokines in Autoimmune Disease
pp. 145-154(10)
Authors: Christopherson II, Kent W.; Hromas, Robert A.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Dendritic Cell Endothelium Interaction in Autoimmunity
pp. 171-181(11)
Authors: Schlichting, C. L.; Schareck, W. D.; Weis, M.

Favourites:
ADD
Favourites:
ADD

Red Blood Cells as Modulators of T Cell Growth and Survival
pp. 191-201(11)
Authors: Arosa, Fernando A.; Pereira, Carlos F.; Fonseca, Ana M.

Favourites:
ADD

Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
pp. 203-211(9)
Authors: Acosta, Juan; Qin, Xuebin; Halperin, Jose

Favourites:
ADD

Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
pp. 213-221(9)
Authors: Lin, Y. S.; Lin, C. F.; Lei, H. Y.; Liu, H. S.; Yeh, T. M.; Chen, S. H.; Liu, C. C.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content